Waters Corp

1WAT

Company Profile

  • Business description

    Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.

  • Contact

    34 Maple Street
    MilfordMA01757
    USA

    T: +1 508 478-2000

    E: [email protected]

    https://www.waters.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    7,900

Stocks News & Analysis

stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,829.5017.300.20%
CAC 408,010.8823.390.29%
DAX 4024,494.58186.660.77%
Dow JONES (US)49,529.44156.68-0.32%
FTSE 10010,340.8417.090.17%
HKSE25,797.85122.670.48%
NASDAQ26,090.73134.41-0.51%
Nikkei 22560,550.59265.36-0.44%
NZX 50 Index12,974.32211.401.66%
S&P 5007,371.2631.79-0.43%
S&P/ASX 2008,604.7023.100.27%
SSE Composite Index4,169.5438.010.92%

Market Movers